Clinical trial
Pivotal Study to Evaluate the Efficacy and Safety of Dermal-Living Skin Replacement (Dermal-LSR) in the Treatment of Chronic Diabetic Foot Ulcers
NCT00387101 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pivotal Study to Evaluate the Efficacy and Safety of Dermal-Living Skin Replacement (Dermal-LSR) in the Treatment of Chronic Diabetic Foot Ulcers
- Lead sponsor
- ApoPharma
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 28, 2006
- Completion date
- April 30, 2008
- Enrollment
- 288 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer